Analysts: AquaBounty must now shift from development to commercialization

Additional financing and strategic moves by company CEO will be key to future success and growth in company's stock price.

The FDA announcement could bring investors the stock that were previously on the sidelines. — The FDA announcement could bring investors the stock that were previously on the sidelines.Foto: AquaBounty

John Fiorillo

Published 11 March 2019, 09:00Updated 11 March 2019, 12:19